SCHIERMEIER ANDREW 4
4 · Intellia Therapeutics, Inc. · Filed May 2, 2018
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (right to buy)
2018-05-01+23,500→ 23,500 totalExercise: $20.56Exp: 2028-04-30→ Common Stock (23,500 underlying)
Footnotes (1)
- [F1]This option was granted on May 1, 2018 with respect to 23,500 shares of Common Stock, with 25% vesting on May 1, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.